Analysts Grow Bullish on Core Scientific (CORZ) After Takeover Vote Fails

Group 1 - Core Scientific, Inc. (NASDAQ:CORZ) has been upgraded by Macquarie to "Outperform" with a new price target of $34.00 following the termination of its planned sale to CoreWeave (CRWV) [1] - Roth Capital has also raised its price target for CORZ from $23.50 to $40 while maintaining a Buy rating, indicating confidence in CORZ's ability to pursue a standalone path and engage with customers after the failed takeover [2] - The company is transitioning into an AI business by leveraging its advanced infrastructure and expertise in high-performance computing (HPC) [3] Group 2 - Despite the potential of CORZ as an investment, there are other AI stocks that may offer greater upside potential and carry less downside risk [3]